Company news
Context Therapeutics Inc. news in 2021
Context Therapeutics Inc.'s news releases, calls and decks from 2021, newest first.
Context Therapeutics® Announces Positive Data from ONA-XR in Early Breast Cancer at 2021 San Antonio Breast Cancer Symposium
December 8, 2021
Context Therapeutics Inc. Announces Closing of $31.25 Million Private Placement
December 5, 2021
Context Therapeutics® Reports Third Quarter 2021 Operating and Financial Results
December 1, 2021
Context Therapeutics Inc. Announces $31.25 Million Private Placement
November 30, 2021
Context Therapeutics® Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Legal Officer
October 31, 2021
Context Therapeutics® and Wisconsin Oncology Network Announce First Patient Dosed in Phase 2 Trial of ONA-XR in Metastatic Breast Cancer
October 26, 2021
Context Therapeutics® Announces Closing of Initial Public Offering, Including Full Exercise of Underwriter’s Over-allotment Option
October 21, 2021
Decks in 2021
- IPO Roadshow (October 2021)
IPO roadshow · 45 slides · Oct 18, 2021
- IPO Roadshow (July 2021)
IPO roadshow · 41 slides · Jul 12, 2021
- IPO Roadshow (July 2021)
IPO roadshow · 42 slides · Jul 2, 2021